批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/05/22 |
SUPPL-45(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2019/10/28 |
SUPPL-44(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/09/14 |
SUPPL-41(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/08/24 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/10/28 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/01/10 |
SUPPL-37(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2011/12/01 |
SUPPL-35(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/03/31 |
SUPPL-33(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/07/01 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/11/26 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/09/28 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/02/14 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/02/12 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/07/14 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/12/11 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/01/13 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/05/16 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/03/17 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1994/07/28 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1993/11/05 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1992/09/23 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1992/09/03 |
SUPPL-17(补充) |
Approval |
Labeling |
|
|
|
1992/05/04 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1991/03/06 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1991/03/06 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1990/01/19 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1989/12/15 |
SUPPL-9(补充) |
Approval |
Efficacy |
|
|
|
1989/08/08 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1989/06/14 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1989/05/17 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1989/03/30 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1988/11/30 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1988/11/30 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1988/11/30 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1988/09/22 |
SUPPL-8(补充) |
Approval |
Labeling |
|
|
|
1988/07/20 |
SUPPL-5(补充) |
Approval |
Labeling |
|
|
|
1987/09/24 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/12/16 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:VERAPAMIL HYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019152 |
001 |
NDA |
CALAN SR |
VERAPAMIL HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Discontinued |
Yes |
No |
AB |
1986/12/16
|
PFIZER |
活性成分:VERAPAMIL HYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019152 |
003 |
NDA |
CALAN SR |
VERAPAMIL HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Discontinued |
Yes |
No |
AB |
1991/03/06
|
PFIZER |